Skip to main content
. Author manuscript; available in PMC: 2014 Jan 16.
Published in final edited form as: Bioconjug Chem. 2013 Jan 7;24(1):85–96. doi: 10.1021/bc300498d

Table 2.

IC50 Values of Different Liposome Formulations on αvβ6-Positive H2009 Cellsa

Drug Formulation IC50 on H2009 cells (nM)
0.6% H2009.1 Tetrameric 1500 ± 200
0.6% scH2009.1 Tetrameric 2400 ± 120
0.6% Naked 7400 ± 1400

1.3% H2009.1 Monomeric 5700 ± 120
1.3% H2009.1 Tetrameric 970 ± 130
1.3% scH2009.1 Tetrameric 2000 ± 330
1.3% Naked Not reachedb

2.0% H2009.1 Tetrameric 360 ± 35
2.0% scH2009.1 Tetrameric 610 ± 90
2.0% Naked 6900 ± 960

Free Doxorubicin 430 ± 75
a

Cells were incubated with liposomes for 1 hour followed by a 120 hour recovery in media.

b

Not reached at the highest treatment concentration of 10.2 μM.

HHS Vulnerability Disclosure